DORI VOSITALARINING FARMATSEVTIK TEXNOLOGIYASI HAMDA ULARNI SANOAT DARAJASIDA ISHLAB CHIQARISH YO‘NALISHLARI
Keywords:
farmatsevtik texnologiya, dori vositalari, sanoat ishlab chiqarish, GMP, granulyatsiya, kapsulyatsiya, 3D bosma, farmatsevtika sanoati, sifat nazorati, innovatsion texnologiyalarAbstract
Ushbu maqolada dori vositalarining farmatsevtik texnologiyasi, ularning sanoat miqyosida ishlab chiqarilishi hamda zamonaviy texnologik jarayonlar tahlil qilingan. Dori vositalarini yaratish bosqichlari, xom ashyo tanlashdan boshlab tayyor dori shaklini olishgacha bo‘lgan jarayonlar ilmiy-nazariy hamda amaliy nuqtai nazardan ko‘rib chiqilgan. Farmatsevtik ishlab chiqarishda qo‘llaniladigan zamonaviy texnologiyalar — granulyatsiya, kapsulyatsiya, liofilizatsiya, mikrokapsulalash, 3D bosma texnologiyalari va boshqa usullar tahlil qilinib, ularning afzalliklari, samaradorligi va iqtisodiy jihatdan ustunliklari ko‘rsatib o‘tilgan. Sanoat darajasida ishlab chiqarish jarayonida GMP (Yaxshi ishlab chiqarish amaliyoti) standartlari, sifatni nazorat qilish tizimi, ekologik xavfsizlik talablari va innovatsion yondashuvlar asosida mahsulot tayyorlashning muhim jihatlari yoritilgan. Bundan tashqari, O‘zbekistonda farmatsevtika sanoatini rivojlantirishga qaratilgan islohotlar, mahalliy ishlab chiqaruvchilar imkoniyatlari va xalqaro tajribaning tatbiqi masalalari ham ko‘rib chiqilgan. Mazkur maqola dori vositalarining zamonaviy texnologik ishlab chiqarilishi bilan shug‘ullanuvchi olimlar, texnologlar va farmatsevtlar uchun amaliy va nazariy ahamiyatga ega
References
1. World Health Organization. Guidelines on Good Manufacturing Practices (GMP) for pharmaceutical products. WHO Technical Report Series, No. 986, Annex 2, 2022. – B. 25–63.
2. Aulton M.E., Taylor K.M.G. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines. 5th ed. Elsevier, 2021. – B. 112–198.
3. Allen L.V., Popovich N.G., Ansel H.C. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 11th ed. Lippincott Williams & Wilkins, 2020. – B. 47–135.
4. Chien Y.W. Novel Drug Delivery Systems. 2nd ed. Marcel Dekker Inc., 2009. – B. 88–172.
5. Lachman L., Lieberman H.A., Kanig J.L. The Theory and Practice of Industrial Pharmacy. 3rd ed. Lea & Febiger, 2009. – B. 232–297.
6. Florence A.T., Attwood D. Physicochemical Principles of Pharmacy. 6th ed. Pharmaceutical Press, 2016. – B. 65–114.
7. Remington, J.P. Remington: The Science and Practice of Pharmacy. 22nd ed. Pharmaceutical Press, 2013. – B. 941–1020.
8. Shargel L., Yu A.B.C. Applied Biopharmaceutics & Pharmacokinetics. 7th ed. McGraw-Hill Education, 2015. – B. 189–243.
9. Banker G.S., Rhodes C.T. Modern Pharmaceutics. 4th ed. Marcel Dekker, 2002. – B. 301–386.
10. United States Pharmacopeia – National Formulary (USP-NF). USP 43–NF 38. United States Pharmacopeial Convention, 2020. – B. 2110–2175.
11. Khar R.K., Vyas S.P., Farhan J. The Textbook of Industrial Pharmacy. CBS Publishers, 2014. – B. 155–204.
12. Rowe R.C., Sheskey P.J., Quinn M.E. Handbook of Pharmaceutical Excipients. 7th ed. Pharmaceutical Press, 2012. – B. 74–132.
13. European Medicines Agency. ICH Guidelines for Pharmaceuticals. EMA Publications, 2021. – B. 15–49.
